Tenderwize
Retour à la recherche

Open House contract for Glycopyrronium bromide/Formoterol

Techniker Krankenkasse·Hamburg, Germany·Deadline Jul 30, 2027 · 338 days left·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-18 - Glycopyrroniumbromid/Formoterol (Wirkstoffkombination)

46/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

46 / 100

Complexité

58 / 100

Facteurs de risque

The notice says contracts cannot be submitted via the procurement portal; they must be sent by email with qualified ele...

Only pharmaceutical companies meeting the AMG-based eligibility conditions for the specific medicines may participate.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Jul 2027
  • Conclude supply contracts for pharmaceutical products relating to Glycopyrroniumbromid/Formoterol.
  • Provide the relevant medicines for the German market nationwide.
Afficher le résumé complet

Open House supply arrangement for pharmaceutical products concerning Glycopyrroniumbromid/Formoterol. The Techniker Krankenkasse seeks to conclude non-exclusive contracts with all suitable pharmaceutical companies under uniform conditions; no individual negotiations are held. The notice states that participation documents are only provided to companies that market or credibly intend to market the relevant medicines during the contract period. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. The procedure is described as not being a public procurement contract in the usual sense, so standard procurement review routes are said not to apply.

Risques

The notice says contracts cannot be submitted via the procurement portal; they must be sent by email with qualified ele...

Only pharmaceutical companies meeting the AMG-based eligibility conditions for the specific medicines may participate.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Applicant must be a pharmaceutical company within the meaning of § 4 Abs. 18 AMG for the relevant medicines.
  • Applicant must have its seat in Germany, another EU Member State, or another EEA State.
  • Applicant must hold a valid marketing authorisation for the relevant medicines or otherwise be entitled to place them on the market in its own name.

Acheteur

Localisation

Hamburg, DEU

Identifiant

992-80116-93

Activité

Health

Lots (1)

LOT-0001

Open House contract for Glycopyrronium bromide/Formoterol

Supply arrangement for the drug combination Glycopyrroniumbromid/Formoterol. Scope is nationwide in Germany. The lot is an Open House Originale contract with uniform terms, no exclusivity, and no individual negotiations. The contract can be joined at any time during the contract period, subject to the stated eligibility conditions and document requirements. Source: structured data and XML notice.

SuppliesEU fundedElectronic submission

Localisation

DE600, Germany

Durée

Jul 2025 - Jul 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Jul 30, 2027

Détails de la procédure

Date de publication
11 May 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
299868-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3